Proton-therapy and concurrent chemotherapy in stage III NSCLC: Effects on toxicity and immune therapy

F. Cortiula; L. Hendriks; R. Wijsman; S. Debakker; M. Steens; S.T. Peeters; A. Michelotti; N.M. Sijtsema; S. Urban; A. Niezink; S. Dursun; G. Bootsma; R. Canters; F. Tohidinezhad; G. Fasola; I. Rinaldi; V. Taasti; R. Houben; D. De Ruysscher

doi:10.1016/j.annonc.2022.07.1083

Proton-therapy and concurrent chemotherapy in stage III NSCLC: Effects on toxicity and immune therapy

F. Cortiula
, L. Hendriks
, R. Wijsman
, S. Debakker
, M. Steens
, S.T. Peeters
, A. Michelotti
, N.M. Sijtsema
, S. Urban
, A. Niezink
, S. Dursun
, G. Bootsma
, R. Canters
, F. Tohidinezhad
, G. Fasola
, I. Rinaldi
, V. Taasti
, R. Houben
, D. De Ruysscher

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	S984-S985
Number of pages	2
Journal	Annals of Oncology
Volume	33
Issue number	S7
DOIs	https://doi.org/10.1016/j.annonc.2022.07.1083
Publication status	Published - Sept-2022
Event	ESMO Congress 2022 - Duration: 9-Sept-2022 → 13-Sept-2022

Access to Document

10.1016/j.annonc.2022.07.1083

Handle.net

Persistent link

Cite this

Cortiula, F., Hendriks, L., Wijsman, R., Debakker, S., Steens, M., Peeters, S. T., Michelotti, A., Sijtsema, N. M., Urban, S., Niezink, A., Dursun, S., Bootsma, G., Canters, R., Tohidinezhad, F., Fasola, G., Rinaldi, I., Taasti, V., Houben, R., & De Ruysscher, D. (2022). Proton-therapy and concurrent chemotherapy in stage III NSCLC: Effects on toxicity and immune therapy. Annals of Oncology, 33(S7), S984-S985. https://doi.org/10.1016/j.annonc.2022.07.1083

@article{3757bbf6ee2b4d12ac150b27cde92349,

title = "Proton-therapy and concurrent chemotherapy in stage III NSCLC: Effects on toxicity and immune therapy",

author = "F. Cortiula and L. Hendriks and R. Wijsman and S. Debakker and M. Steens and S.T. Peeters and A. Michelotti and N.M. Sijtsema and S. Urban and A. Niezink and S. Dursun and G. Bootsma and R. Canters and F. Tohidinezhad and G. Fasola and I. Rinaldi and V. Taasti and R. Houben and \{De Ruysscher\}, D.",

year = "2022",

month = sep,

doi = "10.1016/j.annonc.2022.07.1083",

language = "English",

volume = "33",

pages = "S984--S985",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "S7",

note = "ESMO Congress 2022 ; Conference date: 09-09-2022 Through 13-09-2022",

}

Cortiula, F, Hendriks, L, Wijsman, R, Debakker, S, Steens, M, Peeters, ST, Michelotti, A, Sijtsema, NM, Urban, S, Niezink, A, Dursun, S, Bootsma, G, Canters, R, Tohidinezhad, F, Fasola, G, Rinaldi, I, Taasti, V, Houben, R & De Ruysscher, D 2022, 'Proton-therapy and concurrent chemotherapy in stage III NSCLC: Effects on toxicity and immune therapy', Annals of Oncology, vol. 33, no. S7, pp. S984-S985. https://doi.org/10.1016/j.annonc.2022.07.1083

TY - JOUR

T1 - Proton-therapy and concurrent chemotherapy in stage III NSCLC: Effects on toxicity and immune therapy

AU - Cortiula, F.

AU - Hendriks, L.

AU - Wijsman, R.

AU - Debakker, S.

AU - Steens, M.

AU - Peeters, S.T.

AU - Michelotti, A.

AU - Sijtsema, N.M.

AU - Urban, S.

AU - Niezink, A.

AU - Dursun, S.

AU - Bootsma, G.

AU - Canters, R.

AU - Tohidinezhad, F.

AU - Fasola, G.

AU - Rinaldi, I.

AU - Taasti, V.

AU - Houben, R.

AU - De Ruysscher, D.

PY - 2022/9

Y1 - 2022/9

U2 - 10.1016/j.annonc.2022.07.1083

DO - 10.1016/j.annonc.2022.07.1083

M3 - Meeting Abstract

SN - 0923-7534

VL - 33

SP - S984-S985

JO - Annals of Oncology

JF - Annals of Oncology

IS - S7

T2 - ESMO Congress 2022

Y2 - 9 September 2022 through 13 September 2022

ER -